SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-031881
Filing Date
2020-05-22
Accepted
2020-05-22 20:00:40
Documents
1
Period of Report
2020-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11351
  Complete submission text file 0001209191-20-031881.txt   12999
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OSKAR BAECKSTROMSV.11 HAGERSTEN V7 12935
Business Address
Wigzell Hans Lennart Rudolf (Reporting) CIK: 0001492766 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 20907675